참고문헌
- Holford NH. Target concentration intervention: beyond Y2K. Br J Clin Pharmacol 1999;48:9-13. https://doi.org/10.1046/j.1365-2125.1999.00971.x
- Holford N. Pharmacodynamic principles and the time course of immediate drug effects. Transl Clin Pharmacol 2017;25:157-161. https://doi.org/10.12793/tcp.2017.25.4.157
- Holford N, Yim DS. Clearance. Transl Clin Pharmacol 2015;23:42-45. https://doi.org/10.12793/tcp.2015.23.2.42
- Holford N, Yim DS. Volume of distribution. Transl Clin Pharmacol 2016;24:74-77. https://doi.org/10.12793/tcp.2016.24.2.74
- New Zealand Formulary. Morphine monograph https://nzf.org.nz/nzf_2515.2019.
- Holford NH, Ma SC, Anderson BJ. Prediction of morphine dose in humans. Paediatr Anaesth 2012;22:209-222. doi: 10.1111/j.1460-9592.2011.03782.x.
- Holford N, Black P, Couch R, Kennedy J, Briant R. Theophylline target concentration in severe airways obstruction - 10 or 20 mg/L? A randomised concentration-controlled trial. Clin Pharmacokinet 1993;25:495-505. https://doi.org/10.2165/00003088-199325060-00007
- Holford N, Hashimoto Y, Sheiner LB. Time and theophylline concentration help explain the recovery of peak flow following acute airways obstruction. Population analysis of a randomised concentration controlled trial. Clin Pharmacokinet 1993;25:506-515. https://doi.org/10.2165/00003088-199325060-00008
- Holford N. Pharmacokinetic variability due to environmental differences. Transl Clin Pharmacol 2017;25:59-62. https://doi.org/10.12793/tcp.2017.25.2.59
- Peeters MY, Allegaert K, Blusse van Oud-Alblas HJ, Cella M, Tibboel D, Danhof M, et al. Prediction of propofol clearance in children from an allometric model developed in rats, children and adults versus a 0.75 fixedexponent allometric model. Clin Pharmacokinet 2010;49:269-275. doi: 10.2165/11319350-000000000-00000.
- Holford NH, Buclin T. Safe and effective variability - a criterion for dose individualization. Ther Drug Monit 2012;34:565-568. doi: 10.1097/FTD.0b013e31826aabc3.
- Sheiner L, Tozer T. Clinical pharmacokinetics: The use of plasma concentrations of drugs. Clinical Pharmacology: Basic Principles of Therapeutics. Melmon K, Morelli H. New York, Macmillan. 1978;71-109.
- Sheiner LB, Rosenberg B, Melmon KL. Modelling of individual pharmacokinetics for computer-aided drug dosage. Comput Biomed Res 1972;5:441-459. https://doi.org/10.1016/0010-4809(72)90051-1
- Hale MD, Nicholls AJ, Bullingham RE, Hene R, Hoitsma A, Squifflet JP, et al. The pharmacokinetic-pharmacodynamic relationship for mycophenolate mofetil in renal transplantation. Clin Pharmacol Ther 1998;64:672-683. https://doi.org/10.1016/S0009-9236(98)90058-3
- Le Meur Y, Buchler M, Thierry A, Caillard S, Villemain F, Lavaud S, et al. Individualized mycophenolate mofetil dosing based on drug exposure significantly improves patient outcomes after renal transplantation. Am J Transplant 2007;7:2496-2503. https://doi.org/10.1111/j.1600-6143.2007.01983.x
- van Gelder T, Hilbrands LB, Vanrenterghem Y, Weimar W, de Fijter JW, Squifflet JP, et al. A randomized double-blind, multicenter plasma concentration controlled study of the safety and efficacy of oral mycophenolate mofetil for the prevention of acute rejection after kidney transplantation. Transplantation 1999;68:261-266. https://doi.org/10.1097/00007890-199907270-00018
- Gaston RS, Kaplan B, Shah T, Cibrik D, Shaw LM, Angelis M, et al. Fixedor controlled-dose mycophenolate mofetil with standard- or reduced-dose calcineurin inhibitors: the Opticept trial. Am J Transplant 2009;9:1607-1619. doi: 10.1111/j.1600-6143.2009.02668.x.
피인용 문헌
- Concept and utility of population pharmacokinetic and pharmacokinetic/pharmacodynamic models in drug development and clinical practice vol.71, pp.4, 2018, https://doi.org/10.5937/arhfarm71-32901
- Reinforcement learning and Bayesian data assimilation for model‐informed precision dosing in oncology vol.10, pp.3, 2021, https://doi.org/10.1002/psp4.12588
- Too Much of a Good Thing: Defining Antimicrobial Therapeutic Targets to Minimize Toxicity vol.109, pp.4, 2018, https://doi.org/10.1002/cpt.2190
- Key Challenges in Providing Effective Antibiotic Therapy for Critically Ill Patients with Bacterial Sepsis and Septic Shock vol.109, pp.4, 2018, https://doi.org/10.1002/cpt.2203
- PBPK Modeling and Simulation and Therapeutic Drug Monitoring: Possible Ways for Antibiotic Dose Adjustment vol.9, pp.11, 2021, https://doi.org/10.3390/pr9112087
- Pharmacometabolomics-guided clozapine therapy in treatment resistant schizophrenia: Preliminary exploration of future too near vol.67, pp.None, 2022, https://doi.org/10.1016/j.ajp.2021.102939